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Intracerebral hemorrhage (ICH) is frequent pathology in emergency departments. Coa-
gulopathies leading to ICH are rare. We describe here the case of diagnosis of a chronic
myeloid leukemia from ICH in emergencies.1. Introduction
Intracerebral hemorrhage (ICH) is frequent pathology in
emergency departments. It accounts for 5%–10% of stroke
events[1]. Coagulopathies leading to ICH are rare, and are
divided to acquired and congenital disorders of homeostasis
including bleeding due to neoplasms[1]. Chronic myeloid
leukemia (CML) is one of these acquired coagulopathies that
can be rarely accompanied of ICH in acute or blastic phase.
We describe here the case of diagnosis of a CML from ICH in
emergencies.
2. Case report
A 26-year-old man, with no medical or surgical history
presented to the emergency department for a minor head trauma
caused by a drop height.
His symptoms began that morning. He progressively began
to have moderate intensity headaches which were no better with
paracetamol. He did not complain about vision disorders, butwas nauseous after the meal. His friend decided to bring him to
the emergency department to consult. On the way to the hospital,
he fell with no loss of consciousness, nor amnesia.
The examination in the Emergency's Intensive Care area
found a conscious patient; the Glasgow coma scale was 15
points. A hemiplegia of the left-hand side was objectiﬁed. The
patient pupils were equal, in miosis and reactive to light. No
fever was noted. The patient had a stable hemodynamic and
respiratory state. The abdominal palpation noted a diffuse
abdominal distension with a splenomegaly beyond the umbilicus
and a painless hepatomegaly. Skin examination showed no
purpuric spot.
One hour after his arrival to the hospital, right mydriasis was
objectiﬁed. The patient presented a seizure at the third hour of
his arrival in emergency department, and two episodes of
vomiting. An anticonvulsant treatment was then indicated; the
patient received 15 mg/kg of phenobarbital in 20 min. The pa-
tient continued to have headaches despite the analgesic
treatment.
A contrast-enhanced computerized tomography (CT) of the
head was performed at the third hour after the trauma, which
showed a large hematoma in right subcortical parietal lobe
(65 mm × 50 mm × 45 mm) without enhancement after injection
of contrast and surrounded by edema. The mass effect exerted
from this hematoma resulted in a right to left midline shift. There
were no vascular abnormalities to explain this ICH, nor bone
fracture (Figure 1).served.
Figure 1. Head CT scan done in emergency department.
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mL controlled to 260000/mL) with normal platelet count
(291000/mL controlled to 282000/mL). His prothrombin time
was to 43%. Examination of blood smears allowed presuming
the diagnosis of CML (27% metamyelocytes, 18% myelocytes
and 2% promyelocytes) (Table 1).
Osmotherapy by a 20% mannitol was started as soon as the
CT scan was done. Corticosteroid therapy was also administered
(1 mg/kg dexamethasone intravenously).
An abdominal ultrasound was performed, showing an
enlarged spleen to 27 cm height with regular contours and an
increased kidneys size (right kidney = 13.8 cm, left
kidney = 14.0 cm).
Transfer to neurosurgery department has been agreed with
the neurosurgeon to continue his supervision; no urgent surgical
treatment has been decided. However, the patient became
comatose with a Glasgow coma scale at 11 points followed after
few minutes by a sudden circulatory arrest; his pupils were
unresponsive bilateral mydriasis. Cardiopulmonary resuscitation
was then carried without recovery of spontaneous circulation.
The patient was died in the 12 h of his arrival to the emergency.
The patient's autopsy showed a hemorrhagic brain mass in
right parietal brain lobe. Abdominal autopsy examination has
objectiﬁed an important splenomegaly with homogeneous
hepatomegaly.Table 1
Results of laboratory exams on admission in emergency department.
Variable Value Reference range
White blood cell count (per mm3) 260000 4500–11000
Hemoglobin (g/dL) 8.4 13.5–17.5
Platelet count (per mm3) 291000 150000–350000
Differential count (%)
Neutrophil 38 40–70
Lymphocytes 2 22–44
Blasts 4 0
Erythroblasts 6 0
Metamyelocytes 27 0
Myelocytes 18 0
Promyelocytes 2 0
Monocytes 2 4–11
Eosinophiles 1 0–4
Prothrombin rate (%) 43 70–1003. Discussion
Spontaneous ICH accounts for 5%–10% of stroke events and
has a high mortality[2]. Multiple pathological processes can cause
ICH including trauma, cerebrovascular disease, and coagulation
disorders[3]. The medical history with unusual headache, changes
in mental status or focal neurological deﬁcits leads to practice
non contrast head CT which shows the ICH. It was the case
of our patient. Therefore the cause of ICH must always be
elucidated.
CML accounts for approximately 15% of adult leukemias,
with a male to female ratio of 1–1.3. It's a rare myeloprolifera-
tive disease, with an annual incidence estimated at 1 to 1.5 case
per 100000 inhabitants[4]. The median age of disease discovery
is 45–55 years[5]. The only conﬁrmed predisposing factor is
exposure to ionizing radiation[4]. CML is a disease
characterized by a speciﬁc cytogenetic marker, the
Philadelphia chromosome, which results from a balanced
translocation of segments of chromosomes 9 and 22. The
evolution of this disease may go through three phases: chronic
phase, often prolonged and less severe, followed by the
accelerated phase also called blastic phase and ﬁnally the
acceleration phase. One-quarter of patients present with the
blastic phase, without the preexisting chronic phase being
diagnosed[6], in our case, discovery of the CML was immediately
in the acceleration phase.
The most common clinical signs of CML are loss of weight,
sweating and episodes of abdominal pain due to splenic
infarction or weight of spleen. Priapism was described in rare
cases. In fact, clinical manifestations are mostly absent in
chronic phase[4]. The median time to development of blastic
phase is approximately 36 months before the advent of
interferon therapy, 48 months with interferon therapy and 5
years after allogenic bone marrow transplantation[6]. Recently
the treatment with tyrosine kinase inhibitors can control the
clinical features for years or even decades (10–20 years) in the
majority of patients[4,7]. The onset of additional clinical
ﬁndings, such as fever, adenopathy, splenic enlargement,
general cachexia and progressive immaturity of marrow and
blood granulocytes, is of the blast phase[4,6]. Some atypical
presentation of CML was reported in literature like
neurological involvement including deafness, blindness and
tinnitus.
Leukostasis is clinically suspected when neurological or
respiratory disorders appear in a patient with an important
leukocytosis (>100000/mL for CML). This leukostasis is much
rare in the CML compared to its rate in acute leukemias[3]. The
pathophysiological mechanism of ICH is not yet well
determined; disorders of hemostasis would be implicated, as
well as vascular microthrombosis by leukocytes[3] and it
seems to occur in the accelerated or blastic phase more than
in chronic phase[8]. While ICH is often identiﬁed in autopsy
studies of leukemic patients or in patients diagnosed with
acute leukemia, it is rare for ICH to be the presenting sign
that ultimately leads to the diagnosis of leukemia[3]. The
prognosis at this stage is often fatal the ﬁrst 10 days[3]. ICH
is a grave prognosis indicator in either myelogenous or
lymphoblastic leukemia and is second only to infection as
the most common cause of death[3]. Such is the case of our
patient.
While our clinical report presents an additional case of
spontaneous acute hematoma and describes its association with
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medical history and non-contrast head CT are often necessary
for any patients presenting with symptoms suggestive of po-
tential intracranial pathology and leads often to a diagnose of
ICH. Second, the presence of acute hematoma in the absence of
head trauma should warrant further investigation like the prac-
tice to obtain basic blood work up that includes a complete
blood count, a complete metabolic panel and coagulation studies
for every patient admitted to the emergency[9]. The management
of ICH in cases with coagulopathy is largely medical[3]. Current
recommendations from the American Heart Association give
consideration to surgical evacuation of hemorrhage that is
located within 1 cm of the cortical surface and associated with
substantial mass effect, edema or midline shift[3]. In our case,
treatment was medical because the hematoma was located
within more than 1 cm, so he received transfusion of plasma
regarding his low rate of prothrombin time, and phenobarbital
to seizures.
In conclusion, initial leukemic involvement of the central
neurologic system is perhaps not so unusual in the acceleration
or blastic phases of CML but as emergency physicians, we need
to be aware of this diagnosis. It should be considered in the
differential diagnosis of any situation in which intracerebral or
subarachnoid hemorrhagea, epidural and subdural hematomas[10]
are detected prior to the diagnosis of leukemia with unknown
etiology, particularly in the setting of hyperleukocytosis, and a
characteristically abnormal peripheral blood smear.
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